Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...
The upcoming EU Biotech Act may be more prominently focused on health. But it will also significantly impact food and food ...
Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend ...
Roche has headed back to China to pen a licensing deal worth over $1 billion biobucks for the rights to a clinical-stage bispecific antibody for respiratory diseases. | Roche has headed back to China ...
For biopharma, reaching the right patients at the right time is essential for both clinical and commercial success. The right ...
This analysis reviews the history and current status of biosimilar regulation in the US, concluding that changing the FDA’s interchangeability standards—as proposed by some policy makers—is a ...
Advances in hydrogels and engineered drug delivery systems have significantly impacted medicine since 1995, when Doxil, the first FDA-approved liposomal ...
The field of oncology continues to confront the formidable challenge of addressing cancer, a leading cause of mortality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback